Top

Published in:

Open Access 01-12-2018 | Research article

Implications for the migraine SNP rs1835740 in a Swedish cluster headache population

Authors: Caroline Ran, Carmen Fourier, Margret Zinnegger, Anna Steinberg, Christina Sjöstrand, Elisabet Waldenlind, Andrea Carmine Belin

Published in: The Journal of Headache and Pain | Issue 1/2018

Abstract

Background

Cluster headache is a severe headache disorder with unknown aetiology. The pathophysiology and symptoms present certain common features with migraine. Specifically, activation of the trigeminal vascular system seems to be involved in both disorders, which is hypothesized to result in neurogenic inflammation and vasodilation of the cerebral vessels. In addition, genetic factors have been implicated in both migraine and cluster headache.

Objective

In order to determine whether or not migraine and cluster headache share genetic risk factors, we screened two genetic variants known to increase the risk of migraine in Sweden in a Swedish cluster headache case-control study population.

Methods

In all, 541 patients and 581 control subjects were genotyped for rs1835740 in close proximity to MTDH (metadherin) and rs2651899 in the PRDM16 (PR/SET domain 16) gene, using TaqMan® real-time PCR and pyrosequencing. In addition, we analyzed MTDH gene expression in a subset of the material, using reverse transcription real-time PCR to determine relative mRNA levels in primary fibroblast cell lines from patients and controls.

Results

We found a trend for association between rs1835740, which is reported to affect MTDH mRNA levels, and cluster headache in our Swedish case-control material (p = 0.043, Χ² = 4.102). This association was stronger in a subgroup of patients suffering from both cluster headache and migraine (p = 0.031, Χ² = 6.964). We could further confirm that rs1835740 has an effect on the transcriptional activity of MTDH. In this Swedish cluster headache cohort we did not find an association with the rs2651899 variant.

Conclusions

We conclude that rs1835740 is a potential risk factor for cluster headache in Sweden. Our data indicates that rs1835740 and MTDH might be involved in neurovascular headaches in general whilst rs2651899 is specifically related to migraine.

Bahra A, May A, Goadsby PJ (2002) Cluster headache: a prospective clinical study with diagnostic implications. Neurology 58:354–361CrossRef

Robbins MS, Starling AJ, Pringsheim TM, Becker WJ, Schwedt TJ (2016) Treatment of cluster headache: the American headache society evidence-based guidelines. Headache J Head Face Pain. 56:1093–1106CrossRef

The International Headache Society (IHS) (2018) Headache classification Committee of the International Headache Society (IHS) the international classification of headache disorders, 3rd edition. Cephalalgia 38:1–211

Vollesen AL, Benemei S, Cortese F et al (2018) Migraine and cluster headache – the common link. J Headache Pain 19:89CrossRef

Buture A, Gooriah R, Nimeri R, Ahmed F (2016) Current understanding on pain mechanism in migraine and cluster headache. Anesthesiol pain Med 6:e35190CrossRef

Kudrow L (1987) The cyclic relationship of natural illumination to cluster period frequency. Cephalalgia 7(Suppl 6):76–78CrossRef

Ofte HK, Berg DH, Bekkelund SI, Alstadhaug KB (2013) Insomnia and periodicity of headache in an Arctic cluster headache population. Headache J Head Face Pain. 53:1602–1612CrossRef

Mulder EJ, Van Baal C, Gaist D et al (2003) Genetic and environmental influences on migraine: a twin study across six countries. Twin Res 6:422–431CrossRef

Bjørn Russell M (2004) Epidemiology and genetics of cluster headache. Lancet Neurol 3:279–283CrossRef

10.

Montagna P, Mochi M, Prologo G et al (1998) Heritability of cluster headache. Eur J Neurol 5:343–345CrossRef

11.

Steinberg A, Fourier C, Ran C, Waldenlind E, Sjöstrand C, Belin AC (2018) Cluster headache - clinical pattern and a new severity scale in a Swedish cohort. Cephalalgia 38:1286–1295CrossRef

12.

Rainero I, Gallone S, Valfrè W et al (2004) A polymorphism of the hypocretin receptor 2 gene is associated with cluster headache. Neurology 63:1286–1288CrossRef

13.

Weller CM, Wilbrink LA, Houwing-Duistermaat JJ et al (2015) Cluster headache and the hypocretin receptor 2 reconsidered: a genetic association study and meta-analysis. Cephalalgia 35:741–747CrossRef

14.

Rainero I, Rubino E, Gallone S et al (2010) Cluster headache is associated with the alcohol dehydrogenase 4 (ADH4) gene. Headache 50:92–98CrossRef

15.

Fourier C, Ran C, Steinberg A, Sjöstrand C, Waldenlind E, Carmine Belin A (2016) Screening of two ADH4 variations in a Swedish cluster headache case-control material. Headache 56:835–840CrossRef

16.

Sjöstrand C, Modin H, Masterman T, Ekbom K, Waldenlind E, Hillert J (2002) Analysis of nitric oxide synthase genes in cluster headache. Cephalalgia 22:758–764CrossRef

17.

Rainero I, Rivoiro C, Gallone S et al (2005) Lack of association between the 3092 T→C clock gene polymorphism and cluster headache. Cephalalgia 25:1078–1081CrossRef

18.

Cevoli S, Mochi M, Pierangeli G et al (2008) Investigation of the T3111C CLOCK gene polymorphism in cluster headache. J Neurol 255:299–300CrossRef

19.

Fourier C, Ran C, Zinnegger M et al (2018) A genetic CLOCK variant associated with cluster headache causing increased mRNA levels. Cephalalgia 38:496–502CrossRef

20.

Svensson DA (2004) Etiology of primary headaches: the importance of genes and environment. Expert Rev Neurother 4:415–424CrossRef

21.

Anttila V, Stefansson H, Kallela M et al (2010) Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nat Genet 42:869–873CrossRef

22.

Chasman DI, Schurks M, Anttila V et al (2011) Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat Genet 43:695–698CrossRef

23.

Freilinger T, Anttila V, de Vries B et al (2012) Genome-wide association analysis identifies susceptibility loci for migraine without aura. Nat Genet 44:777–782CrossRef

24.

Ligthart L, de Vries B, Smith AV et al (2011) Meta-analysis of genome-wide association for migraine in six population-based European cohorts. Eur J Hum Genet 19:901–907CrossRef

25.

Cox HC, Lea RA, Bellis C et al (2012) A genome-wide analysis of “bounty” descendants implicates several novel variants in migraine susceptibility. Neurogenetics 13:261–266CrossRef

26.

Ran C, Graae L, Magnusson PKE, Pedersen NL, Olson L, Belin AC (2014) A replication study of GWAS findings in migraine identifies association in a Swedish case-control sample. BMC Med Genet 15:38

27.

Sintas C, Fernández-Morales J, Vila-Pueyo M et al (2015) Replication study of previous migraine genome-wide association study findings in a Spanish sample of migraine with aura. Cephalalgia 35:776–782CrossRef

28.

Fan X, Wang J, Fan W et al (2014) Replication of migraine GWAS susceptibility loci in Chinese Han population. Headache 54:709–715CrossRef

29.

An XK, Ma QL, Lin Q, Zhang XR, Lu CX, Qu HL (2013) PRDM16 rs2651899 variant is a risk factor for chinese common migraine patients. Headache 53:1595–1601CrossRef

30.

Anttila V, Winsvold BS, Gormley P et al (2013) Genome-wide meta-analysis identifies new susceptibility loci for migraine. Nat Genet 45:912–917CrossRef

31.

Gormley P, Anttila V, Winsvold BS et al (2015) Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. bioRxiv 48:16–18

32.

Esserlind A-L, Christensen AF, Le H et al (2013) Replication and meta-analysis of common variants identifies a genome-wide significant locus in migraine. Eur J Neurol 20:765–772CrossRef

33.

Sintas C, Carreno O, Fernandez-Morales J et al (2012) A replication study of a GWAS finding in migraine does not identify association in a Spanish case-control sample. Cephalalgia 32:1076–1080CrossRef

34.

Ghosh J, Pradhan S, Mittal B (2013) Genome-wide-associated variants in migraine susceptibility: a replication study from North India. Headache 53:1683–1694CrossRef

35.

Stovner L, Hagen K, Jensen R et al (2007) The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27:193–210CrossRef

36.

Azimova J, Kondratieva N, Sergeev A et al (2015) The role of polymorphism of regulatory region of MTDH gene (Rs1835740) in migraine and other forms of primary headaches. J Neurol Stroke 3:101

37.

Kudrow L, Kudrow DB (1994) Inheritance of cluster headache and its possible link to migraine. Headache J Head Face Pain. 34:400–407CrossRef

38.

Schürks M, Neumann FA, Kessler C et al (2011) MTHFR 677C>T Polymorphism and Cluster Headache. Headache J Head Face Pain 51:201–207CrossRef

39.

Samaan Z, Gaysina D, Cohen-Woods S et al (2011) Methylenetetrahydrofolate reductase gene variant (MTHFR C677T) and migraine: a case control study and meta-analysis. BMC Neurol 11:66CrossRef

40.

Rainero I, Rubino E, Valfrè W et al (2007) Association between the G1246A polymorphism of the hypocretin receptor 2 gene and cluster headache: a meta-analysis. J Headache Pain. 8:152–156CrossRef

41.

Pinessi L, Binello E, De Martino P et al (2007) The 1246G→A polymorphism of the HCRTR2 gene is not associated with migraine. Cephalalgia 27:945–949CrossRef

42.

De OS, Mansur T, Gonçalves FM, Martins-Oliveira A et al (2012) Inducible nitric oxide synthase haplotype associated with migraine and aura. Mol Cell Biochem 364:303–308CrossRef

43.

Gonçalves FM, Luizon MR, Speciali JG, Martins-Oliveira A, Dach F, Tanus-Santos JE (2012) Interaction among nitric oxide (NO)-related genes in migraine susceptibility. Mol Cell Biochem 370:183–189CrossRef

44.

The International Headache Society (IHS) (2004) The international classification of headache disorders: 2nd edition. Cephalalgia 24 Suppl1:9–160

45.

Ekbom K, Svensson DA, Pedersen NL, Waldenlind E (2006) Lifetime prevalence and concordance risk of cluster headache in the Swedish twin population. Neurology 67:798–803CrossRef

46.

Zuker M (2003) Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31:3406–3415CrossRef

47.

Takashima A (1998) Establishment of fibroblast cultures. Curr Protoc Cell Biol 2:1–12

48.

Johansson A-S, Owe-Larsson B, Hetta J, Lundkvist GB (2016) Altered circadian clock gene expression in patients with schizophrenia. Schizophr Res 174:17–23CrossRef

49.

Wang Y, Wei Y, Tong H et al (2015) MiR-302c-3p suppresses invasion and proliferation of glioma cells via down-regulating metadherin (MTDH) expression. Cancer Biol Ther 16:1308–1315CrossRef

50.

Häbig K, Gellhaar S, Heim B et al (2013) LRRK2 guides the actin cytoskeleton at growth cones together with ARHGEF7 and tropomyosin 4. Biochim Biophys Acta - Mol Basis Dis 1832:2352–2367CrossRef

51.

Rodriguez S, Gaunt TR, Day INM (2008) Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol 169:505–514CrossRef

52.

Kang D-C, Su Z-Z, Sarkar D, Emdad L, Volsky DJ, Fisher PB (2005) Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. Gene 353:8–15CrossRef

53.

Lee S-G, Kim K, Kegelman TP et al (2011) Oncogene AEG-1 promotes glioma-induced neurodegeneration by increasing glutamate excitotoxicity. Cancer Res 71:6514–6523CrossRef

54.

Bullaughey K, Chavarria CI, Coop G, Gilad Y (2009) Expression quantitative trait loci detected in cell lines are often present in primary tissues. Hum Mol Genet 18:4296–4303CrossRef

55.

Anttila V, Wessman M, Kallela M, Palotie A (2011) Towards an understanding of genetic predisposition to migraine. Genome Med 3:17CrossRef

56.

Pietrobon D (2007) Familial hemiplegic migraine. Neurotherapeutics 4:274–284CrossRef

57.

Curto M, Lionetto L, Negro A et al (2015) Altered serum levels of kynurenine metabolites in patients affected by cluster headache. J Headache Pain. 17:27CrossRef

58.

Vécsei L, Szalárdy L, Fülöp F, Toldi J Kynurenines in the CNS: recent advances and new questions. Nat. Rev. Drug Discov.. Nature Publishing Group 2013, 12:64–82CrossRef

Title: Implications for the migraine SNP rs1835740 in a Swedish cluster headache population
Authors: Caroline Ran
Carmen Fourier
Margret Zinnegger
Anna Steinberg
Christina Sjöstrand
Elisabet Waldenlind
Andrea Carmine Belin
Publication date: 01-12-2018
Publisher: Springer Milan
Published in: The Journal of Headache and Pain / Issue 1/2018
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI: https://doi.org/10.1186/s10194-018-0937-0

At a glance: The STEP trials

Springer Medicine

Implications for the migraine SNP rs1835740 in a Swedish cluster headache population

Abstract

Background

Objective

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Objective

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2018

Assessment of community pharmacy professionals’ knowledge and counseling skills achievement towards headache management: a cross-sectional and simulated-client based mixed study

Dihydroergotamine inhibits the vasodepressor sensory CGRPergic outflow by prejunctional activation of α2-adrenoceptors and 5-HT1 receptors

Correction to: Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)

Long-term follow-up of a community sample of adolescents with frequent headaches

Fremanezumab blocks CGRP induced dilatation in human cerebral, middle meningeal and abdominal arteries

The headache under-response to treatment (HURT) questionnaire, an outcome measure to guide follow-up in primary care: development, psychometric evaluation and assessment of utility